RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29

REVVITY, INC.

Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Aug 11, 2026

$150.94−1.70 (-1.11%)

Close on Oct 19, 2026

Market cap: $16.85B
P/E (TTM): 71.9
Dividend yield: 0.19%

Fundamental chart

Pick a measure to chart its full history

$2.86BFY2025, +2.9% a year since FY2011

Where these numbers come from

Parsed from the XBRL in Revvity's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 4, 2001
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RVTY.

Revenue growth4.1% · median 4.9%

Operating margin12.3% · median 10.8%

Net margin8.2% · median 18.4%

Company	Revenue	Growth
A	$7.37B	+8.6%
ILMN	$4.49B	+4.9%
MTD	$4.13B	+6.9%
BRKR	$3.50B	+1.6%
RVTY	$2.91B	+4.1%
BIO	$2.59B	+1.4%

Company

Next earnings (est.): Oct 26, 2026, before open
Exchange: NYSE
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 29
Employees: 11,000
Held by institutions: 100.0%
Auditor: DELOITTE & TOUCHE LLP
SEC CIK: 31791

Advertisement
300 × 250